
Denoreg 2mg Tablet
Marketer
Pharmison Valentes Pharma Pvt Ltd
Salt Composition
Dienogest (2mg)
Overview Denoreg 2mg Tablet
Endometriosis-related pelvic pain is treated with the 2mg Denoreg tablet. This medication contains a progestin, a hormone similar to those naturally produced, which acts by reducing hormone production associated with endometriosis. Denoreg 2mg can be administered with or without food, but consistent daily timing is recommended for optimal results. Dosage and frequency depend on individual needs and are determined by your physician, adjusted to effectively manage your symptoms. Swallow the tablets whole with water. Continue the prescribed course of treatment, including throughout menstruation. Common side effects include acne, headache, mood changes, breast tenderness, nausea, and ovarian cysts. Report any persistent or concerning side effects to your doctor; management strategies may be available. Irregular menstrual cycles, spotting, or mid-cycle brown discharge are common; however, consult your physician for frequent occurrences. Prior to starting Denoreg, inform your doctor of any history of unexplained vaginal or uterine bleeding, circulatory disorders, and all other medications you are currently taking, as interactions may affect the drug's efficacy or action. Disclose pregnancy, pregnancy plans, or breastfeeding before commencing treatment.
Primary Ingredients of Denoreg 2mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Denoreg 2mg Tablet
Managing endometriosis-related pelvic discomfort
Major Benefits of Denoreg 2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Denoreg 2mg Tablet can be administered with or without food, although consistent timing is recommended.
Common Side effects of Denoreg 2mg Tablet:
- Headache
- Acne
- Breast pain
- Abnormal menstrual bleeding
- Weight gain
- Sleep disorder
- Nervousness
- Loss of libido
- Migraine
- Gastrointestinal disturbance
- Hair loss
- Back pain
- Breast engorgement
- Ovarian cysts
- Hot flushes
- Vaginal bleeding
- Asthenic conditions
- Irritability
How to use Denoreg 2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 2mg Denoreg tablet whole; avoid chewing, crushing, or fracturing it. While it can be taken with or without food, consistency is key – aim for a regular daily intake.
How Denoreg 2mg Tablet works:
Estradiol suppression, achieved through the progestin Denoreg 2mg Tablet, reduces endometrial hyperplasia. This medication's mechanism involves inhibiting estradiol production.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Denoreg 2mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
Using Denoreg 2mg tablets during pregnancy poses a considerable risk. Pregnant individuals should consult their physician; research in animals and pregnant women indicates substantial harm to the fetus.
Breast feedingCONSULT YOUR DOCTOR
Administering Denoreg 2mg tablets while breastfeeding may pose a risk. Available human data indicates potential transfer to breast milk, possibly harming the infant.
DrivingSAFE
Driving ability is typically unaffected by Denoreg 2mg Tablets.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Denoreg 2mg Tablet use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with liver disease should use Denoreg 2mg Tablets cautiously, potentially requiring dose modification. Consult your physician. Dienogest is contraindicated in those with severe liver dysfunction.
What if you forget to take Denoreg 2mg Tablet :
NA
Facts to Know About Denoreg 2mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Androgens Derived from 19-Nortestosterone |
| Developing Habits | No. |
| Treatment Category | OBSTETRIC AND GYNECOLOGICAL |
| Actions | Third-Generation Progestins |
